Jen Coleman

Jen Coleman is an active researcher specializing in RNA-binding proteins and their role in cancer biology. Her work focuses on understanding the molecular mechanisms of LARP4 proteins in cell proliferation, tumor growth, and metastasis.

Education:

• PhD in Molecular Biology/Biochemistry (June 2022) - Thesis: "Investigating the Functions and Mechanisms of the LARP4 RNA-Binding Proteins in Cancer" under supervisors A.E. Grigoriadis and M.R. Conte

Dr. Coleman's research centers on RNA-binding proteins, particularly the LARP4 family, and their implications in cancer development and progression. Her work spans molecular mechanisms of cell proliferation, programmed cell death, tumor suppression pathways, and tissue repair. The fingerprint analysis of her research shows strong activity in RNA-binding Protein (100%), Cell Proliferation (44%), Tissue Repair (33%), Enzyme studies (33%), Tumor Suppressor Proteins (33%), Programmed Cell Death (33%), Paralogy (33%), and Messenger RNA (33%).

Her publication record demonstrates a clear trajectory focusing on LARP4 proteins in cancer, with her most recent work (2025) examining LARP4's interaction with ribosome-associated RACK1 and translation promotion. She has also contributed to interdisciplinary research through the T2K Collaboration in particle physics, showing versatility across scientific domains.

With 24 total citations across her 7 research outputs (4 articles, 2 preprints, and 1 short survey), Dr. Coleman's work contributes to UN Sustainable Development Goals related to good health and well-being.